Presentation Information

[3F-08]Company Introduction

*Akihito Sawada1, Yusuke Okada1, Takeru Yamakawa1 (1. Infectious Disease Control Labs, Group 1 Drug Discovery Department Meiji Seika Pharma Co., Ltd. (Japan))

Keywords:

Infection disease,Vaccine,Covid-19

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in